Impact de l'élargissement des lignes directrices sur le traitement de l'hépatite B : une modélisation et une analyse de l'impact économique
Summary Antiviral treatment in patients with chronic hepatitis B (CHB) may decrease the risk of hepatocellular carcinoma (HCC) and death. However, only 2.2% of CHB patients receive antiviral treatment globally. The complexity and strictness of the current clinical practice guidelines may limit expanding the treatment coverage for CHB. We examined the impact of expanding treatment […]
French 
English 
Spanish 
Russian 
Arabic